Today's volume is less than 1/2 of 1% percent of total stock on issue. Very encouraging announcement though. Australian investors still in the mounting yard.
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025